Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Veru Inc.

Clinical trials sponsored by Veru Inc., explained in plain language.

Veru Inc. VERU NASDAQ

A biopharmaceutical company developing therapies for oncology and infectious diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

New combo pill aims to melt fat, not muscle, in weight loss

Disease control Recruiting now

This Phase 2b trial tests whether adding enobosarm (a muscle-preserving drug) to semaglutide (a weight-loss drug) helps older adults lose more fat and keep muscle. About 200 people aged 65 and older who are overweight or obese will take both drugs or semaglutide alone. The goal i…

Phase: PHASE2 • Sponsor: Veru Inc. • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC